It’s Ethical to Pay COVID Volunteers

It is ethically appropriate to pay volunteers who are intentionally infected with the COVID virus as part of clinical research, says an international panel of experts.

In a report published in the American Journal of Bioethics, the group of ethicists, lawyers, academics, laymen and others from the UK, United States, and Canada found that paying participants in a COVID study should be decided the same way as other human infection challenge studies (HICS) and other, traditional types of clinical trials and research studies.

“Our work was spurred by concerns that payment for SARS-CoV-2 HICS might require a novel ethical framework, which we ultimately determined to be unfounded,” wrote lead author Holly Fernandez Lynch, an assistant professor of medical ethics at the University of Pennsylvania.

The report states that, “The basic framework for ethical research payment divides payment into three categories — reimbursement, compensation, and incentive — and emphasizes the importance of fairness and adequate recruitment and retention, with efforts to minimize undue influence, participant deception about their eligibility and adverse events, and negative impacts on public trust.

“The basic framework is relevant to payment for all types of clinical research, including HICS. Nonetheless, there are factors within that basic framework likely to be particularly salient to setting payment amounts for HICS, including participant isolation and confinement, anticipated discomfort, risk of lasting harm, and participant motivations.”

The panel concluded that payments for HICS and in particular for possible studies involving infection with the COVID virus, “will likely be on the high end of the payment spectrum.”

The report was sponsored by 1Day Sooner, an organization that promotes the use of human challenge trials. Unlike the trials bioscience companies like Pfizer and Modena used to test their vaccines, HCIS researchers intentionally inject volunteers with the virus they are testing against to study their reaction.

It is not uncommon to pay participants in clinical studies. Most often the payments are modest, compensating volunteers them for direct expenses and for their time. Some studies offer additional payments as incentives to recruit enough volunteers, including from diverse communities.

1Day Sooner assembled the study group – paying some of its members – to get an independent assessment of the ethics of whether and how much people should get paid to take part in COVID challenge trials. Such a study is planned in the United Kingdom.

The published report discusses multiple factors of the decision framework the group outlines, ultimately concluding that payment decision-making for HCIS – and COVID studies — should be the same as for all other clinical research involving human subjects.

Image by PIRO4D

#WeAreGreenKey: Spotlight on Lucas Leitenberger
Architecture + Engineering

#WeAreGreenKey: Spotlight on Lucas Leitenberger

Biotech vs. Techbio: A Nexus of Biology and Tech
General Interest

Biotech vs. Techbio: A Nexus of Biology and Tech

Cancer Vaccines: A New Hope
General Interest

Cancer Vaccines: A New Hope

Navigating Quarterly Reviews with Confidence
General Interest

Navigating Quarterly Reviews with Confidence

#WeAreGreenKey: Spotlight on Meryl Schoen
General Interest Professional Support

#WeAreGreenKey: Spotlight on Meryl Schoen

Mastering Hiring Algorithms as a Candidate
General Interest

Mastering Hiring Algorithms as a Candidate

Tips for Creating Effective Corporate Videos for Social Media
General Interest

Tips for Creating Effective Corporate Videos for Social Media

The Power of Video on Corporate Social Media
General Interest

The Power of Video on Corporate Social Media

#WeAreGreenKey: Spotlight on Antonia Piazza
General Interest

#WeAreGreenKey: Spotlight on Antonia Piazza

Strategies for Equitable Employee Development
General Interest

Strategies for Equitable Employee Development

Anthropic Unveils Claude 3: Redefining AI Chatbots with Enhanced Capabilities
Information Technology

Anthropic Unveils Claude 3: Redefining AI Chatbots with Enhanced Capabilities

#WeAreGreenKey: Spotlight on Mike Bosco
Accounting + Finance General Interest

#WeAreGreenKey: Spotlight on Mike Bosco

Marketing Strategies: 2024 Trends and Strategies for Success
General Interest

Marketing Strategies: 2024 Trends and Strategies for Success

The Essence of Marketing Strategy: Driving Business Success (Part II)
General Interest

The Essence of Marketing Strategy: Driving Business Success (Part II)

The Essence of Marketing Strategy: Driving Business Success
General Interest

The Essence of Marketing Strategy: Driving Business Success

Mastering Task Prioritization for Stress Reduction
General Interest

Mastering Task Prioritization for Stress Reduction

Crafting the Future: Delving into AI as a College Major
General Interest Information Technology

Crafting the Future: Delving into AI as a College Major

Mary-Kate Bula Selected as Assistant Coach of the USA Women’s Flag Football National Team
General Interest Pharma

Mary-Kate Bula Selected as Assistant Coach of the USA Women’s Flag Football National Team

Leveraging LinkedIn Polls: A Strategic Tool for Business Insights
General Interest

Leveraging LinkedIn Polls: A Strategic Tool for Business Insights

#WeAreGreenKey: Spotlight on Kyle Gierke
General Interest Healthcare

#WeAreGreenKey: Spotlight on Kyle Gierke

Latest Blog Posts
View All Posts
#WeAreGreenKey: Spotlight on Lucas Leitenberger

#WeAreGreenKey: Spotlight on Lucas Leitenberger

Welcome back to #WeAreGreenKey, where we shine a spotlight on our powerhouse recruiting team.  We recently met up with Lucas...
Read More
Biotech vs. Techbio: A Nexus of Biology and Tech

Biotech vs. Techbio: A Nexus of Biology and Tech

In the dynamic world of scientific innovation, two terms have emerged as guiding lights: Biotech and Techbio. These terms encapsulate...
Read More
Cancer Vaccines: A New Hope

Cancer Vaccines: A New Hope

Cancer vaccines stand as a beacon of hope in the realm of cancer treatment, diverging from traditional vaccines designed to...
Read More